Organization Overview
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (2 trials)
acetylsalicylic acid (aspirin) (23 trials)
allopurinol (zyloprim) (7 trials)
ambrisentan (letairis) (2 trials)
amlodipine (norvasc) (5 trials)
amodiaquine (camoquin) (1 trial)
amprenavir (agenerase) (1 trial)
aripiprazole (abilify) (1 trial)
atenolol (tenormin) (9 trials)
atorvastatin (lipitor) (15 trials)
azithromycin (zithromax) (7 trials)
bnt162b2 (Comirnaty) (2 trials)
budesonide (rhinocort) (9 trials)
bupropion (wellbutrin) (4 trials)
chlorthalidone (Hygroton) (9 trials)
clonidine (catapres) (1 trial)
clopidogrel (plavix) (10 trials)
colesevelam (welchol) (1 trial)
dabigatran (pradaxa) (2 trials)
desipramine (pertofrane) (1 trial)
dexmedetomidine (precedex) (5 trials)
doxazosin (cardura) (3 trials)
enfuvirtide (fuzeon) (1 trial)
escitalopram (lexapro) (4 trials)
estradiol (progynon depot) (6 trials)
evolocumab (repatha) (1 trial)
ferric derisomaltose (Monoferric) (1 trial)
fish oil (Omegavan) (12 trials)
fludeoxyglucose f-18 (1 trial)
fluticasone (cutivate) (12 trials)
formoterol (foradil) (2 trials)
heparin (liquaemin) (3 trials)
hepatitis b vaccine (recombinant) (Recombivax) (3 trials)
hydrochlorothiazide (esidrix) (4 trials)
hydromorphone (diladid) (2 trials)
icosapent ethyl (vascepa) (18 trials)
inactivated influenza vaccine (4 trials)
indinavir (crixivan) (1 trial)
ipratropium (atrovent) (3 trials)
irradiated donor lymphocyte (1 trial)
lamivudine (epivir) (2 trials)
lopinavir (Kaletra) (2 trials)
metformin (glucophage) (4 trials)
metoprolol (lopressor) (6 trials)
mirtazapine (remeron) (1 trial)
mometasone (elocon) (4 trials)
montelukast (singulair) (8 trials)
mrna-1273 (Spikevax) (1 trial)
nelfinavir (viracept) (1 trial)
nevirapine (viramune) (1 trial)
nicotine (nicorette) (11 trials)
olmesartan (benicar) (1 trial)
pegvisomant (somavert) (1 trial)
pioglitazone (actos) (7 trials)
pitavastatin (livalo) (2 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)
pravastatin (pravachol) (7 trials)
prednisolone (hydeltra) (1 trial)
prednisone (meticorten) (13 trials)
progesterone (progestasert) (7 trials)
quinapril (accupril) (2 trials)
raltegravir (isentress) (1 trial)
rivaroxaban (xarelto) (4 trials)
rosuvastatin (crestor) (3 trials)
sacubitril (Entresto) (1 trial)
salmeterol (serevent) (8 trials)
saquinavir (invirase) (1 trial)
sertraline (zoloft) (3 trials)
sildenafil (viagra) (13 trials)
simvastatin (zocor) (11 trials)
sitagliptin (januvia) (8 trials)
spironolactone (aldactone) (13 trials)
testosterone (delatestryl) (2 trials)
theophylline (synophylate) (3 trials)
ticagrelor (brilinta) (2 trials)
tipranavir (aptivus) (1 trial)
tobramycin (nebcin) (3 trials)
trandolapril (mavik) (1 trial)
varenicline (chantix) (3 trials)
varicella zoster virus glycoprotein e antigen (Shingrix) (2 trials)
acetaminophen (tylenol) (1 trial)
acetylcysteine (mucomyst) (2 trials)
albuterol (proventil) (8 trials)
alendronic acid (fosamax) (1 trial)
aliskiren (tekturna) (1 trial)
allogeneic bone marrow (5 trials)
allogeneic cord blood (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (25 trials)
allogeneic stem cells (1 trial)
alpha-1 antitrypsin (Prolastin) (2 trials)
alteplase (Activase) (6 trials)
amiodarone (cordarone) (6 trials)
antihemophilic factor viii human (Hemofil M) (1 trial)
antilymphocyte serum (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (19 trials)
autologous cd34+ cells (4 trials)
autologous hematopoietic stem cells (17 trials)
autologous mononuclear stem cell (3 trials)
autologous umbilical cord blood (8 trials)
beclomethasone (vanceril) (5 trials)
benazepril (lotensin) (1 trial)
beta carotene (solatene) (2 trials)
betamethasone (celestone) (1 trial)
bone marrow derived mesenchymal stem cells (4 trials)
bone marrow derived mononuclear cells (2 trials)
bortezomib (velcade) (5 trials)
bosentan (tracleer) (3 trials)
busulfan (Myleran) (13 trials)
calfactant (infasurf) (1 trial)
candesartan (atacand) (4 trials)
chlorothiazide (diuril) (1 trial)
cisatracurium (nimbex) (1 trial)
clarithromycin (biaxin) (1 trial)
clofibrate (atromid-s) (2 trials)
colchicine (colbenemid) (5 trials)
colestipol (colestid) (2 trials)
conjugated equine estrogens (Premarin) (5 trials)
cyclophosphamide (cytoxan) (45 trials)
cyclosporine (sandimmune) (45 trials)
cytarabine (cytosar-u) (4 trials)
dalteparin (fragmin) (2 trials)
darbepoetin alfa (aranesp) (1 trial)
dextrothyroxine (choloxin) (2 trials)
diltiazem (cardizem) (4 trials)
dipyridamole (persantine) (3 trials)
disopyramide (norpace) (1 trial)
eculizumab (Soliris) (3 trials)
enalapril (vasotec) (6 trials)
esomeprazole (nexium) (1 trial)
etanercept (enbrel) (3 trials)
felodipine (plendil) (1 trial)
fenofibrate (fenoglide) (5 trials)
ferric carboxymaltose (Injectafer) (1 trial)
flecainide (tambocor) (3 trials)
fluconazole (diflucan) (3 trials)
fludarabine (fludara) (48 trials)
ganciclovir (cytovene) (2 trials)
glimepiride (amaryl) (1 trial)
glucagon-like peptide-1 (1 trial)
glycopyrronium (robinul) (1 trial)
haloperidol (haldol) (1 trial)
human factor ix complex (prothrombin complex concentrate) (Bebulin) (1 trial)
hyaluronidase (bovine) (Wydase) (1 trial)
hydralazine (apresoline) (2 trials)
hydroxychloroquine (plaquenil) (2 trials)
hydroxyurea (hydrea) (16 trials)
imipramine (tofranil) (3 trials)
immune globulin (human) (Gamastan) (4 trials)
indacaterol (arcapta neohaler) (1 trial)
indomethacin (indocin) (1 trial)
insulin detemir (Levemir) (1 trial)
insulin glargine (toujeo) (2 trials)
insulin human (humulin) (6 trials)
insulin lispro (humalog) (1 trial)
iron dextran (Imferon) (2 trials)
isosorbide (isordil) (3 trials)
ketoconazole (nizoral) (1 trial)
lenalidomide (revlimid) (5 trials)
levocarnitine (carnitor) (1 trial)
lidocaine (xylocaine) (2 trials)
liraglutide (victoza) (2 trials)
lisinopril (zestril) (2 trials)
lovastatin (mevacor) (5 trials)
maraviroc (selzentry) (2 trials)
medroxyprogesterone (provera) (4 trials)
melphalan (alkeran) (7 trials)
methylprednisolone (medrol) (9 trials)
mexiletine (mexitil) (2 trials)
moricizine (ethmozine) (3 trials)
mycophenolate (CellCept) (34 trials)
naltrexone (revia) (17 trials)
nandrolone phenpropionate (Durabolin) (1 trial)
nedocromil (tilade) (2 trials)
nifedipine (procardia) (2 trials)
nitric oxide (inomax) (7 trials)
nitroglycerin (transderm-nitro) (5 trials)
procainamide (pronestyl) (3 trials)
procaine benzylpenicillin (novocaine) (2 trials)
remdesivir (Veklury) (2 trials)
repaglinide (prandin) (1 trial)
reserpine (serpasil) (2 trials)
rituximab (rituxan) (10 trials)
ruxolitinib (jakafi) (2 trials)
sargramostim (leukine) (19 trials)
sirolimus (rapamune) (19 trials)
soybean oil (Intralipid) (1 trial)
streptokinase (streptase) (2 trials)
tacrolimus (prograf) (18 trials)
thalidomide (Thalomid) (2 trials)
tiotropium (spiriva) (2 trials)
tositumomab (Bexxar) (1 trial)
tranexamic acid (cyklokapron) (2 trials)
triamcinolone (kenalog) (1 trial)
triamterene (dyrenium) (1 trial)
voriconazole (vfend) (3 trials)
acebutolol (sectral) (1 trial)
acetylcholine chloride (miochol) (7 trials)
adenovirus-5 encoding human adenylyl cyclase type 6 (1 trial)
alemtuzumab (campath) (13 trials)
alglucosidase alfa (myozyme) (1 trial)
alirocumab (praluent) (1 trial)
allogeneic adipose derived mesenchymal stem cell (4 trials)
allogeneic cardiosphere-derived cells (2 trials)
allogeneic lymphocytes (4 trials)
allogeneic mesenchymal stem cells (2 trials)
anastrozole (arimidex) (1 trial)
arsenic trioxide (trisenox) (1 trial)
atomoxetine (strattera) (2 trials)
autologous bone marrow derived cd34+ hsc cells transduced with the lentiviral vector containing a short-hairpin rna targeting bcl11a (1 trial)
autologous mesenchymal stem cells (10 trials)
azathioprine (imuran) (1 trial)
Bacterial Lysates (pulmonarom) (1 trial)
biotin labeled rbcs (2 trials)
biotinylated red blood cells (3 trials)
cat epidermis allergen (4 trials)
celecoxib (celebrex) (2 trials)
ciprofloxacin (cipro) (1 trial)
citalopram (celexa) (2 trials)
colfosceril palmitate (1 trial)
cord blood hematopoietic stem cell (2 trials)
crizanlizumab (Adakveo) (1 trial)
cyanocobalamin (berocca) (1 trial)
daclizumab (Zenapax) (2 trials)
danazol (danocrine) (2 trials)
dapagliflozin (farxiga) (1 trial)
darunavir (prezista) (1 trial)
daunorubicin (cerubidine) (1 trial)
decitabine (dacogen) (3 trials)
deferiprone (ferriprox) (1 trial)
deferoxamine (desferal) (2 trials)
dendritic cell tumor fusion vaccine (1 trial)
denileukin diftitox (ontak) (1 trial)
dobutamine (dobutrex) (3 trials)
drotrecogin alfa, activated (Xigris) (2 trials)
droxidopa (northera) (1 trial)
duvelisib (copiktra) (1 trial)
efs-ada transduced cd34+ bone marrow cells (1 trial)
eltrombopag (promacta) (8 trials)
ethambutol (myambutol) (1 trial)
fenfluramine (Pondimin) (1 trial)
Filgrastim (neupogen) (1 trial)
fosinopril (monopril) (1 trial)
haploidentical mononuclear cells (1 trial)
house dust mite allergen (5 trials)
ibrutinib (imbruvica) (4 trials)
interferon alpha-2b (Intron-A) (2 trials)
levofloxacin (levaquin) (1 trial)
liothyronine (cytomel) (2 trials)
low molecular weight iron dextran (1 trial)
lucinactant (surfaxin) (1 trial)
lv-nyeso tcr /sr39tk pbsc (1 trial)
lymphocyte immune globulin, anti-thymocyte globulin (equine) (Atgam) (3 trials)
metoclopramide (reglan) (1 trial)
minocycline (minocin) (3 trials)
mitapivat (Pyrukynd) (2 trials)
multivirus specific t cells (1 trial)
nesiritide (natrecor) (5 trials)
octreotide (sandostatin) (1 trial)
ofatumumab (arzerra) (1 trial)
oxybutynin (ditropan) (1 trial)
parathyroid hormone (Natpara) (1 trial)
pembrolizumab (keytruda) (2 trials)
pentostatin (nipent) (3 trials)
pentoxifylline (trental) (3 trials)
perfluorobutane (Sonazoid) (1 trial)
perflutren protein-type a microspheres (Optison) (1 trial)
peripheral blood lymphocytes (2 trials)
phentermine (wyamine) (1 trial)
phosphatidylglycerol (1 trial)
pirfenidone (esbriet) (1 trial)
plerixafor (mozobil) (8 trials)
pyridoxal isonicotinoyl hydrazone (1 trial)
regadenoson (lexiscan) (5 trials)
ribavirin (virazole) (2 trials)
rilonacept (arcalyst) (1 trial)
roflumilast (daliresp) (2 trials)
sapropterin (kuvan) (3 trials)
sodium ferric gluconate complex (1 trial)
sodium phenylbutyrate (buphenyl) (1 trial)
sucroferric oxyhydroxide (Venofer) (1 trial)
suvorexant (belsomra) (1 trial)
teduglutide (gattex kit) (1 trial)
tezacaftor (Trifakta) (1 trial)
tretinoin (Retin-A) (2 trials)
trivirus specific ctls for ebv, cmv and adenovirus infection (1 trial)
umbilical cord mesenchymal stem cells (2 trials)
ursodeoxycholic acid (1 trial)
venetoclax (venclexta) (1 trial)
wt1 126-134 peptide (3 trials)
xenon-129 (Xenoview) (6 trials)
18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose (FDG) (1 trial)
18f 4-l-fluoroglutamine (1 trial)
adenosine (Adenocard) (1 trial)
adenovirus-specific t-cells (1 trial)
aldesleukin (Proleukin) (1 trial)
allogeneic natural killer cells (1 trial)
autologous bone marrow derived mesenchymal cells (1 trial)
c46/ccr5/p140k lentiviral vector-transduced autologous hspcs (1 trial)
cetrorelix (cetrotide) (1 trial)
chlorhexidine (hibitane) (1 trial)
clofarabine (clolar) (1 trial)
cmv-specific t-cells (1 trial)
cromoglicic acid (Intal) (1 trial)
empagliflozin (jardiance) (1 trial)
eszopiclone (lunesta) (2 trials)
ew-a-401 dna plasmid vector (1 trial)
fanconi anemia gene transduced bone marrow cell (1 trial)
fluoxetine (prozac) (2 trials)
fx-5a peptide complex (1 trial)
gadofosveset trisodium (ablavar) (1 trial)
gadopenteate dimeglumine (magnevist) (1 trial)
genetically engineered hematopoietic stem cells (1 trial)
herv-e tcr transduced cd8+/cd34+ t cells in hlaa* 11:01 positive patients (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
Hydroxymethylfurfural (1 trial)
live attenuated influenza virus vaccine (Flumist) (1 trial)
lung spheroid stem cells (1 trial)
mannitol (Osmitrol) (2 trials)
methyltestosterone (testred) (1 trial)
miconazole (monistat) (1 trial)
midodrine (proamatine) (1 trial)
alfalfa sprout homogenate (1 trial)
allogeneic blood cells (1 trial)
aminocaproic acid (amicar) (1 trial)
corticotropin (acthar) (1 trial)
desflurane (suprane) (1 trial)
florbetapir (Amyvid) (1 trial)
infliximab (remicade) (1 trial)
Abnormalities, Drug-Induced (Phase 4)
Acidosis (Phase 2)
Acidosis, Lactic (Phase 2)
Acquired Immunodeficiency Syndrome (Phase 4)
Acute Chest Syndrome (Phase 3)
Acute Coronary Syndrome (Phase 4)
Acute Lung Injury (Phase 4)
Acute Pain (Phase 4)
Adenoviridae Infections (Phase 2)
Aggression (Phase 2)
AIDS-Related Complex (Phase 2)
Albuminuria (Phase 2)
alpha 1-Antitrypsin Deficiency (Phase 2)
Alzheimer Disease (Phase 3)
Anemia (Phase 3)
Anemia, Aplastic (Phase 3)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Congenital (Phase 2)
Anemia, Iron-Deficiency (Phase 3)
Anemia, Neonatal (Phase 2)
Anemia, Refractory (Phase 2)
Anemia, Sickle Cell (Phase 4)
Aneurysm (Phase 3)
Angina Pectoris (Phase 3)
Angina, Unstable (Phase 4)
Angioedema (Phase 1)
Apnea (Phase 4)
Arachnodactyly (Phase 3)
Arrhythmia, Sinus (Phase 3)
Arterial Occlusive Diseases (Phase 3)
Arteriosclerosis (Phase 3)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Ascites (Phase 2)
Aspergillosis (Phase 2)
Aspergillosis, Allergic Bronchopulmonary (Phase 2)
Asthma (Phase 4)
Atherosclerosis (Phase 4)
Atrial Fibrillation (Phase 4)
Atrophy (Phase 1)
Autonomic Nervous System Diseases (Phase 1)
Beriberi (Phase 2)
beta-Thalassemia (Phase 2)
Birth Weight (Phase 4)
Blast Crisis (Phase 2)
Blood Coagulation Disorders (Phase 3)
Bone Diseases (Phase 3)
Bone Marrow Diseases (Phase 1)
Brain Injuries (Phase 3)
Brain Injuries, Traumatic (Phase 3)
Breast Neoplasms (Phase 3)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Bronchitis (Phase 4)
Bronchitis, Chronic (Phase 4)
Bronchopulmonary Dysplasia (Phase 3)
Burkitt Lymphoma (Phase 3)
Calcinosis (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Medullary (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiomegaly (Phase 2)
Cardiomyopathies (Phase 4)
Cardiomyopathy, Dilated (Phase 4)
Cardiomyopathy, Hypertrophic (Phase 3)
Cardio-Renal Syndrome (Phase 2)
Cardiovascular Diseases (Phase 4)
Carotid Artery Diseases (Phase 4)
Carotid Stenosis (Phase 2)
Cataract (Phase 3)
Cerebrovascular Disorders (Phase 3)
Chest Pain (Phase 4)
Chickenpox (Phase 2)
Chlamydia Infections (Phase 2)
Cognitive Dysfunction (Phase 4)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 4)
Congenital Abnormalities (Phase 4)
Connective Tissue Diseases (Phase 4)
Constriction, Pathologic (Phase 2)
Coronary Aneurysm (Phase 3)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronavirus Infections (Phase 3)
Cough (Phase 2)
Critical Illness (Phase 4)
Cystic Fibrosis (Phase 4)
Cytomegalovirus Infections (Phase 3)
Death (Phase 3)
Death, Sudden (Phase 3)
Death, Sudden, Cardiac (Phase 3)
Deficiency Diseases (Phase 3)
Delirium (Phase 3)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Depressive Disorder, Major (Phase 4)
Diabetes, Gestational (Phase 1)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Retinopathy (Phase 3)
Disease (Phase 3)
Disease Progression (Phase 1)
Down Syndrome (Phase 2)
Ductus Arteriosus, Patent (Phase 3)
Dyslipidemias (Phase 4)
Dyspnea (Phase 2)
Dyssomnias (Phase 2)
Eclampsia (Phase 2)
Embolism (Phase 4)
Embolism and Thrombosis (Phase 3)
Emphysema (Phase 4)
Endocardial Cushion Defects (Phase 2)
Endocrine System Diseases (Phase 3)
Endometrial Hyperplasia (Phase 2)
Endomyocardial Fibrosis (Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Essential Hypertension (Phase 2)
Eye Diseases (Phase 3)
Familial Primary Pulmonary Hypertension (Phase 4)
Fanconi Anemia (Phase 2)
Fanconi Syndrome (Phase 2)
Fibrosis (Phase 4)
Gastroesophageal Reflux (Phase 1)
Gingivitis (Phase 2)
Glucose Intolerance (Phase 2)
Glucose Metabolism Disorders (Phase 4)
Glycogen Storage Disease Type II (Phase 2)
Graft vs Host Disease (Phase 3)
Granulomatosis with Polyangiitis (Phase 3)
Granulomatous Disease, Chronic (Phase 2)
Heart Arrest (Phase 3)
Heart Defects, Congenital (Phase 3)
Heart Diseases (Phase 4)
Heart Failure (Phase 4)
Heart Failure, Diastolic (Phase 4)
Heart Failure, Systolic (Phase 2)
Heart Septal Defects (Phase 3)
Heart Septal Defects, Ventricular (Phase 3)
Hematologic Diseases (Phase 4)
Hematologic Neoplasms (Phase 2)
Hemochromatosis (Phase 3)
Hemoglobinopathies (Phase 3)
Hemoglobin SC Disease (Phase 2)
Hemoglobinuria (Phase 3)
Hemoglobinuria, Paroxysmal (Phase 3)
Hemolysis (Phase 2)
Hemophilia A (Phase 3)
Hemophilia B (Phase 1)
Hemorrhage (Phase 3)
Hemorrhagic Disorders (Phase 3)
Hemostatic Disorders (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 1)
Hepatitis, Viral, Human (Phase 3)
Hepatopulmonary Syndrome (Phase 2)
Herpes Zoster (Phase 2)
HIV-Associated Lipodystrophy Syndrome (Phase 4)
HIV Infections (Phase 4)
HIV Seropositivity (Phase 2)
Hodgkin Disease (Phase 2)
Hyaline Membrane Disease (Phase 3)
Hypercholesterolemia (Phase 4)
Hyperglycemia (Phase 2)
Hyperinsulinism (Phase 1)
Hyperlipidemias (Phase 4)
Hyperlipoproteinemias (Phase 4)
Hyperlipoproteinemia Type II (Phase 3)
Hyperplasia (Phase 3)
Hypersensitivity (Phase 1)
Hypertension (Phase 4)
Hypertension, Pregnancy-Induced (Phase 3)
Hypertension, Pulmonary (Phase 4)
Hypertriglyceridemia (Phase 4)
Hypertrophy (Phase 3)
Hyperuricemia (Phase 4)
Hypoglycemia (Phase 4)
Hypoxia (Phase 3)
Idiopathic Pulmonary Fibrosis (Phase 3)
Immune System Diseases (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Immunologic Deficiency Syndromes (Phase 3)
Immunoproliferative Disorders (Phase 1)
Infant, Newborn, Diseases (Phase 3)
Infarction (Phase 4)
Infections (Phase 4)
Inflammation (Phase 4)
Influenza, Human (Phase 4)
Insulin Resistance (Phase 3)
Intermittent Claudication (Phase 3)
Intracranial Arteriosclerosis (Phase 3)
Intracranial Embolism (Phase 3)
Intracranial Embolism and Thrombosis (Phase 3)
Iron Overload (Phase 2)
Ischemia (Phase 4)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Kidney Neoplasms (Phase 2)
Leg Ulcer (Phase 1)
Leukemia (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Accelerated Phase (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 2)
Leukemia, T-Cell (Phase 2)
Li-Fraumeni Syndrome (Phase 2)
Lipid Metabolism Disorders (Phase 3)
Lipodystrophy (Phase 4)
Liver Diseases (Phase 3)
Long QT Syndrome (Phase 4)
Lung Diseases (Phase 3)
Lung Diseases, Interstitial (Phase 2)
Lung Diseases, Obstructive (Phase 3)
Lung Injury (Phase 4)
Lung Neoplasms (Phase 1)
Lupus Erythematosus, Systemic (Phase 1)
Lymphangioleiomyomatosis (Phase 3)
Lymphangiomyoma (Phase 2)
Lymphatic Diseases (Phase 1)
Lymphocytosis (Phase 1)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Macular Degeneration (Phase 3)
Malaria (Phase 4)
Malaria, Falciparum (Phase 4)
Marfan Syndrome (Phase 3)
Melanoma (Phase 2)
Metabolic Diseases (Phase 4)
Metabolic Syndrome (Phase 4)
Metabolism, Inborn Errors (Phase 3)
Mitral Valve Insufficiency (Phase 3)
Mood Disorders (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Multiple Myeloma (Phase 3)
Multiple System Atrophy (Phase 1)
Muscle Weakness (Phase 2)
Mycobacterium Infections (Phase 2)
Mycoses (Phase 3)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 4)
Myocarditis (Phase 2)
Nasal Polyps (Phase 4)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms by Histologic Type (Phase 1)
Neoplasms, Plasma Cell (Phase 3)
Neuroblastoma (Phase 1)
Neurologic Manifestations (Phase 2)
Neutropenia (Phase 3)
Obesity (Phase 4)
Obesity, Abdominal (Phase 2)
Obstetric Labor Complications (Phase 3)
Orthostatic Intolerance (Phase 2)
Osteoporosis (Phase 3)
Out-of-Hospital Cardiac Arrest (Phase 3)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 4)
Pancreatic Neoplasms (Phase 3)
Pancytopenia (Phase 3)
Parasomnias (Phase 2)
Pediatric Obesity (Phase 3)
Peripheral Arterial Disease (Phase 4)
Peripheral Vascular Diseases (Phase 4)
Plasmablastic Lymphoma (Phase 3)
Pleural Effusion (Phase 2)
Pneumonia (Phase 3)
Pneumonia, Bacterial (Phase 2)
Polycystic Ovary Syndrome (Phase 4)
Polycythemia (Phase 2)
Polycythemia Vera (Phase 2)
Polyps (Phase 4)
Postphlebitic Syndrome (Phase 3)
Postthrombotic Syndrome (Phase 3)
Prediabetic State (Phase 2)
Pre-Eclampsia (Phase 3)
Prehypertension (Phase 4)
Preleukemia (Phase 3)
Premature Birth (Phase 3)
Primary Dysautonomias (Phase 1)
Primary Myelofibrosis (Phase 2)
Proteinuria (Phase 2)
Pseudomonas Infections (Phase 3)
Psoriasis (Phase 4)
Pulmonary Aspergillosis (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Pulmonary Embolism (Phase 4)
Pulmonary Emphysema (Phase 4)
Pulmonary Fibrosis (Phase 3)
Pulmonary Heart Disease (Phase 1)
Pulmonary Valve Stenosis (Phase 2)
Pure Autonomic Failure (Phase 1)
Purpura (Phase 3)
Purpura, Thrombocytopenic (Phase 3)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Purpura, Thrombotic Thrombocytopenic (Phase 3)
Radiation Injuries (Phase 1)
Raynaud Disease (Phase 3)
Recurrence (Phase 2)
Red-Cell Aplasia, Pure (Phase 2)
Renal Insufficiency (Phase 2)
Renal Insufficiency, Chronic (Phase 2)
Respiratory Aspiration (Phase 2)
Respiratory Distress Syndrome (Phase 4)
Respiratory Distress Syndrome, Newborn (Phase 4)
Respiratory Insufficiency (Phase 3)
Respiratory Sounds (Phase 4)
Respiratory Tract Infections (Phase 3)
Retinal Diseases (Phase 3)
Retinopathy of Prematurity (Phase 3)
Rhinitis (Phase 4)
Rhinitis, Allergic (Phase 1)
Rhinitis, Allergic, Perennial (Phase 1)
Rhinitis, Allergic, Seasonal (Phase 1)
Sarcoidosis (Phase 2)
Sarcoidosis, Pulmonary (Phase 2)
Scleroderma, Diffuse (Phase 4)
Scleroderma, Localized (Phase 3)
Scleroderma, Systemic (Phase 4)
Sclerosis (Phase 4)
Sepsis (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Shock (Phase 3)
Shock, Hemorrhagic (Phase 3)
Shock, Septic (Phase 3)
Shock, Traumatic (Phase 3)
Shy-Drager Syndrome (Phase 1)
Sinusitis (Phase 4)
Sleep Apnea, Obstructive (Phase 4)
Sleep Apnea Syndromes (Phase 4)
Sleep Wake Disorders (Phase 2)
ST Elevation Myocardial Infarction (Phase 2)
Stroke (Phase 3)
Substance-Related Disorders (Phase 2)
Syndrome (Phase 4)
Systemic Vasculitis (Phase 3)
Tachycardia (Phase 3)
Tachycardia, Ventricular (Phase 3)
Tetralogy of Fallot (Phase 2)
Thalassemia (Phase 3)
Thiamine Deficiency (Phase 2)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 3)
Thrombocytosis (Phase 2)
Thromboembolism (Phase 4)
Thrombophlebitis (Phase 3)
Thrombosis (Phase 4)
Tissue Adhesions (Phase 2)
Tobacco Use Disorder (Phase 4)
Toxemia (Phase 3)
Transposition of Great Vessels (Phase 1)
Tuberculosis (Phase 2)
Uterine Diseases (Phase 2)
Vascular Calcification (Phase 3)
Vascular Diseases (Phase 4)
Vasculitis (Phase 2)
Venous Thromboembolism (Phase 4)
Venous Thrombosis (Phase 4)
Ventricular Dysfunction (Phase 2)
Ventricular Dysfunction, Left (Phase 2)
Ventricular Fibrillation (Phase 3)
Virus Diseases (Phase 2)
Vitamin D Deficiency (Phase 3)
Waldenstrom Macroglobulinemia (Phase 3)
Weight Loss (Phase 2)
Wilms Tumor (Phase 2)
Wounds and Injuries (Phase 4)